PIONEER AF-PCI

Posted by on

Prevention of bleeding in patients with AF undergoing PCI - The New England Journal of Medicine - 2016

Brief Summary:

Among patients with nonvalvular AF undergoing PCI with stent placement, the use of low dose rivaroxaban plus either single or dual antiplatelet therapy reduces the risk of bleeding when compared to warfarin plus DAPT at 1 year.

Reference: http://www.ncbi.nlm.nih.gov/pubmed/27959713

Comments

Post a Comment

Drop your thoughts here, we would love to hear from you